Sign In
Buy TNDM
$18.03
-0.570 (-3.06%)
At Close: Jun 03, 2026
Here's Why Investors Should Retain Tandem Diabetes (TNDM) Now
01:55pm, Wednesday, 22'nd Jun 2022
Investors are optimistic about Tandem Diabetes' (TNDM) strong pump shipments and ongoing product innovations.
Tandem Diabetes Care, Inc. (TNDM) Soars 6%: Is Further Upside Left in the Stock?
12:53pm, Monday, 20'th Jun 2022 Zacks Investment Research
Tandem Diabetes Care, Inc. (TNDM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further st
Tandem Diabetes Care, Inc. (TNDM) Soars 6%: Is Further Upside Left in the Stock?
10:06am, Monday, 20'th Jun 2022
Tandem Diabetes Care, Inc. (TNDM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further st
3 Humbled Nasdaq Stocks Ready to Bounce Back
12:19pm, Tuesday, 14'th Jun 2022 The Motley Fool
These names are at the bottom of the bargain bin.
2 Beaten-Down Stocks With 80% to 113% Upside, According to Wall Street
03:30pm, Wednesday, 08'th Jun 2022 The Motley Fool
These diabetes specialists are down but not out.
2 Beaten-Down Stocks With 80% to 113% Upside, According to Wall Street
11:30am, Wednesday, 08'th Jun 2022
These diabetes specialists are down but not out.
Tandem Diabetes (TNDM) Posts Positive Control-IQ Study Data
02:10pm, Tuesday, 07'th Jun 2022 Zacks Investment Research
Data presented at the ADA conference demonstrates Tandem Diabetes' (TNDM) Control-IQ technology's ability to make a positive and sustained impact across a diverse group of people with diabetes.
Why Is Tandem Diabetes Care, Inc. (TNDM) Down 16.3% Since Last Earnings Report?
03:31pm, Friday, 03'rd Jun 2022 Zacks Investment Research
Tandem Diabetes Care, Inc. (TNDM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tandem Diabetes (TNDM) Pump Shipment Recovers, Price Issue Ails
12:37pm, Tuesday, 31'st May 2022 Zacks Investment Research
Tandem Diabetes (TNDM) witnesses strong customer retention, driven by the impressive positive response from the Control-IQ technology.
Tandem Diabetes (TNDM) Pump Shipment Recovers, Price Issue Ails
09:48am, Tuesday, 31'st May 2022
Tandem Diabetes (TNDM) witnesses strong customer retention, driven by the impressive positive response from the Control-IQ technology.
The Correction In Biopharmaceutical Stocks Is Likely Over
04:51am, Wednesday, 18'th May 2022 Seeking Alpha
Biopharmaceutical stocks have undergone a dramatic correction over the past six months, with the XBI declining by 45%. I highlight stocks that are attractively priced.
6 Analysts Have This to Say About Tandem Diabetes Care
07:27pm, Thursday, 05'th May 2022 Benzinga
Within the last quarter, Tandem Diabetes Care (NASDAQ:TNDM) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
3
2
0
0
Tandem Diabetes (TNDM) Q1 Earnings Lag Estimates, Sales View Up
01:44pm, Thursday, 05'th May 2022 Zacks Investment Research
Robust pump shipments and growth in the installed customer base are driving Tandem Diabetes' (TNDM) first-quarter top line.
Tandem Diabetes (TNDM) Q1 Earnings Lag Estimates, Sales View Up
11:22am, Thursday, 05'th May 2022
Robust pump shipments and growth in the installed customer base are driving Tandem Diabetes' (TNDM) first-quarter top line.
Tandem Diabetes Care, Inc. (TNDM) CEO John Sheridan on Q1 2022 Results - Earnings Call Transcript
07:09pm, Wednesday, 04'th May 2022
Tandem Diabetes Care, Inc. (NASDAQ:TNDM ) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Susan Morrison - EVP and Chief Administrative Officer John Sheridan - President a
